Biomaterial company Biorthex floats in Canada
This article was originally published in Clinica
Executive Summary
Canada's Biorthex hopes to raise up to US$10 million in an initial public offering and will use the money to develop Actipore, a technology platform with multiple biomedical and industrial applications. The company chose to make the offering in Quebec because it offers good fiscal exemptions on special programmes.